❮ Back to Researchers

Gordon Moe

MD, MSc

Associate Scientist, Li Ka Shing Knowledge Institute

Email: MoeG@smh.ca
Tel: 416-864-5615

Research Programs

Biography

My basic/bench research activities involve the use of a canine model of rapid pacing to study mechanisms of progression of heart failure. My clinical research activities involve the assessment of ultrafiltration and the use of biomarker including B-type natriuretic peptide and new biomarkers in the management of acute and chronic heart failure, as well as the quality of care in heart failure. I am also interested in the assessment of the interaction of ethnicity with cardiovascular disease.

Recent Publications

  1. O'Meara, E, McDonald, M, Chan, M, Ducharme, A, Ezekowitz, JA, Giannetti, N et al.. CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis. Can J Cardiol. 2020;36 (2):159-169. doi: 10.1016/j.cjca.2019.11.036. PubMed PMID:32036861 .
  2. Nerenberg, KA, Zarnke, KB, Leung, AA, Dasgupta, K, Butalia, S, McBrien, K et al.. Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children. Can J Cardiol. 2018;34 (5):506-525. doi: 10.1016/j.cjca.2018.02.022. PubMed PMID:29731013 .
  3. Ezekowitz, JA, O'Meara, E, McDonald, MA, Abrams, H, Chan, M, Ducharme, A et al.. 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure. Can J Cardiol. 2017;33 (11):1342-1433. doi: 10.1016/j.cjca.2017.08.022. PubMed PMID:29111106 .
  4. Leung, AA, Daskalopoulou, SS, Dasgupta, K, McBrien, K, Butalia, S, Zarnke, KB et al.. Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults. Can J Cardiol. 2017;33 (5):557-576. doi: 10.1016/j.cjca.2017.03.005. PubMed PMID:28449828 .
  5. Roth, S, Fernando, C, Azeem, S, Moe, GW. Is There a Role for Ivabradine in the Contemporary Management of Patients with Chronic Heart Failure in Academic and Community Heart Failure Clinics in Canada?. Adv Ther. 2017;34 (6):1340-1348. doi: 10.1007/s12325-017-0529-4. PubMed PMID:28432646 .
  6. Leung, AA, Nerenberg, K, Daskalopoulou, SS, McBrien, K, Zarnke, KB, Dasgupta, K et al.. Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. Can J Cardiol. 2016;32 (5):569-88. doi: 10.1016/j.cjca.2016.02.066. PubMed PMID:27118291 .
  7. Moe, GW, Marín-García, J. Role of cell death in the progression of heart failure. Heart Fail Rev. 2016;21 (2):157-67. doi: 10.1007/s10741-016-9532-0. PubMed PMID:26872675 .
  8. Howlett, JG, Chan, M, Ezekowitz, JA, Harkness, K, Heckman, GA, Kouz, S et al.. The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice. Can J Cardiol. 2016;32 (3):296-310. doi: 10.1016/j.cjca.2015.06.019. PubMed PMID:26391749 .
  9. Daskalopoulou, SS, Rabi, DM, Zarnke, KB, Dasgupta, K, Nerenberg, K, Cloutier, L et al.. The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol. 2015;31 (5):549-68. doi: 10.1016/j.cjca.2015.02.016. PubMed PMID:25936483 .
  10. Moe, GW, Ezekowitz, JA, O'Meara, E, Lepage, S, Howlett, JG, Fremes, S et al.. The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: anemia, biomarkers, and recent therapeutic trial implications. Can J Cardiol. 2015;31 (1):3-16. doi: 10.1016/j.cjca.2014.10.022. PubMed PMID:25532421 .
Search PubMed

Affiliations & Other Activities

  • Director, Heart Failure Program and Biomarker Laboratory, Cardiology, St. Michael’s Hospital
  • Professor, Department of Medicine, St. Michael’s Hospital
X